Demand for Antipsychotic Drugs in USA

Demand for Antipsychotic Drugs in USA Size and Share Forecast Outlook 2025 to 2035

Demand for antipsychotic drugs in USA is projected to grow from USD 3.29 billion in 2025 to USD 5.90 billion by 2035, registering 6.0% CAGR. By disease, the schizophrenia segment holds 41.20% of antipsychotic drugs demand in 2025. In terms of therapeutic class, second generation (atypical) applications are expected to represent 64.80% of antipsychotic drugs demand in 2025.

FACT12517MR
11 Dec 2025
Healthcare
170 Pages
6 Tables
21 Figures

Table of Content

Executive Summary
- USA Market Outlook
- Demand to side Trends
- Supply to side Trends
- Technology Roadmap Analysis
- Analysis and Recommendations
Market Overview
- Market Coverage / Taxonomy
- Market Definition / Scope / Limitations
Market Background
- Market Dynamics
  - Drivers
  - Restraints
  - Opportunity
  - Trends
- Scenario Forecast
  - Demand in Optimistic Scenario
  - Demand in Likely Scenario
  - Demand in Conservative Scenario
- Opportunity Map Analysis
- Product Life Cycle Analysis
- Supply Chain Analysis
- Investment Feasibility Matrix
- Value Chain Analysis
- PESTLE and Porter’s Analysis
- Regulatory Landscape
- Regional Parent Market Outlook
- Production and Consumption Statistics
- Import and Export Statistics
USA Market Analysis 2020 to 2024 and Forecast, 2025 to 2035
- Historical Market Size Value (USD Billion) Analysis, 2020 to 2024
- Current and Future Market Size Value (USD Billion) Projections, 2025 to 2035
  - YoY Growth Trend Analysis
  - Absolute $ Opportunity Analysis
USA Market Pricing Analysis 2020 to 2024 and Forecast 2025 to 2035
USA Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Disease
- Introduction / Key Findings
- Historical Market Size Value (USD Billion) Analysis By Disease, 2020 to 2024
- Current and Future Market Size Value (USD Billion) Analysis and Forecast By Disease, 2025 to 2035
  - Schizophrenia
  - Bipolar Disorder
  - Unipolar Depression
  - Dementia-related Psychosis
  - Others
- Y to o to Y Growth Trend Analysis By Disease, 2020 to 2024
- Absolute $ Opportunity Analysis By Disease, 2025 to 2035
USA Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Drug
- Introduction / Key Findings
- Historical Market Size Value (USD Billion) Analysis By Drug, 2020 to 2024
- Current and Future Market Size Value (USD Billion) Analysis and Forecast By Drug, 2025 to 2035
  - Aripiprazole
  - Risperidone
  - Olanzapine
  - Quetiapine
  - Brexpiprazole
  - Paliperidone Palmitate
  - Others
- YoY Growth Trend Analysis By Drug, 2020 to 2024
- Absolute $ Opportunity Analysis By Drug, 2025 to 2035
USA Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Region
- Introduction
- Historical Market Size Value (USD Billion) Analysis By Region, 2020 to 2024
- Current Market Size Value (USD Billion) Analysis and Forecast By Region, 2025 to 2035
  - USA
- Market Attractiveness Analysis By Region
USA Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
- Historical Market Size Value (USD Billion) Trend Analysis By Market Taxonomy, 2020 to 2024
- Market Size Value (USD Billion) Forecast By Market Taxonomy, 2025 to 2035
  - By Country
  - By Drug
  - By Disease
- Market Attractiveness Analysis
  - By Country
  - By Drug
  - By Disease
- Key Takeaways
Market Structure Analysis
- Competition Dashboard
- Competition Benchmarking
- Market Share Analysis of Top Players
  - By Regional
  - By Drug
  - By Disease
Competition Analysis
- Competition Deep Dive
  - H. Lundbeck A/S
    - Overview
    - Product Portfolio
    - Profitability by Market Segments (Product/Age /Sales Channel/Region)
    - Sales Footprint
    - Strategy Overview
      - Marketing Strategy
      - Product Strategy
      - Channel Strategy
    - Otsuka Pharmaceutical Company Limited
    - Janssen Pharmaceuticals Incorporated
    - Eli Lilly and Company
    - AbbVie Incorporated
    - Teva Pharmaceutical Industries Limited
    - Dr. Reddy's Laboratories Limited
    - Sumitomo Pharma Company Limited
    - Alkermes plc
    - Bristol-Myers Squibb Company
Assumptions & Acronyms Used
Research Methodology

List Of Table

Table 1: USA Market Value (USD Billion) Forecast by Region, 2020 to 2035
Table 2: USA Market Value (USD Billion) Forecast by Disease, 2020 to 2035
Table 3: USA Market Value (USD Billion) Forecast by Drug, 2020 to 2035
Table 4: USA Market Value (USD Billion) Forecast by Country, 2020 to 2035
Table 5: USA Market Value (USD Billion) Forecast by Disease, 2020 to 2035
Table 6: USA Market Value (USD Billion) Forecast by Drug, 2020 to 2035

List Of Figures

Figure 1: USA Market Pricing Analysis
Figure 2: USA Market Value (USD Billion) Forecast 2020 to 2035
Figure 3: USA Market Value Share and BPS Analysis by Drug, 2025 and 2035
Figure 4: USA Market YoY Growth Comparison by Drug, 2025 to 2035
Figure 5: USA Market Attractiveness Analysis by Drug
Figure 6: USA Market Value Share and BPS Analysis by Disease, 2025 and 2035
Figure 7: USA Market YoY Growth Comparison by Disease, 2025 to 2035
Figure 8: USA Market Attractiveness Analysis by Disease
Figure 9: USA Market Value (USD Billion) Share and BPS Analysis by Region, 2025 and 2035
Figure 10: USA Market YoY Growth Comparison by Region, 2025 to 2035
Figure 11: USA Market Attractiveness Analysis by Region
Figure 12: USA Market Incremental Dollar Opportunity, 2025 to 2035
Figure 13: USA Market Value Share and BPS Analysis by Country, 2025 and 2035
Figure 14: USA Market Value Share and BPS Analysis by Drug, 2025 and 2035
Figure 15: USA Market YoY Growth Comparison by Drug, 2025 to 2035
Figure 16: USA Market Attractiveness Analysis by Drug
Figure 17: USA Market Value Share and BPS Analysis by Disease, 2025 and 2035
Figure 18: USA Market YoY Growth Comparison by Disease, 2025 to 2035
Figure 19: USA Market Attractiveness Analysis by Disease
Figure 20: USA Market - Tier Structure Analysis
Figure 21: USA Market - Company Share Analysis

Demand for Antipsychotic Drugs in USA

Free Sample Buy Report Now